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A B S T R A C T
Numerous studies have tested the effect of multicomponent post-discharge smoking cessation interventions on
post-discharge smoking cessation, and many are effective. However, little is known regarding the relative effi-
cacy of the different intervention components on short or long-term cessation. The present study is a secondary
analysis (n=984) of a randomized controlled trial for hospitalized smokers that took place at two large hos-
pitals in Kansas from 2011 to 2014. All study participants were offered post-discharge quitline services.
Pharmacotherapy was recommended during bedside tobacco treatment. The study outcomes were self-reported
cessation at 1-month and biochemically verified cessation at 6-months post-randomization. During the post-
discharge period, 69% of participants completed at least one quitline call and 28% of participants reported using
cessation pharmacotherapy. After controlling for known predictors of cessation among hospitalized smokers,
both the number of total quitline calls completed post-discharge and use of cessation pharmacotherapy post-
discharge were predictive of cessation at 1-month. After accounting for predictors of cessation and quitting at 1-
month, total post-discharge quitline calls was associated with cessation at 6-months (OR [95% CI]=1.23 [1.12,
1.35], p < 0.001) while post-discharge cessation pharmacotherapy use was not. The results suggest that both
engagement in quitline services and use pharmacotherapy independently facilitate cessation beyond the influ-
ence of known clinical characteristics associated with cessation. Over the longer term, the effect of engaging in
quitline services persists while the effect of pharmacotherapy diminishes. To optimize outcomes, future research
should investigate methods to increase utilization of medications and promote sustained counseling engagement
in order to sustain the effects of treatment during the post-discharge period.
1. Introduction
An estimated 7 million tobacco users are admitted to hospitals in the
U.S. annually ( CDC 2010; Wier et al., 2011), and hospitalization has
proved to be an effective setting for treating tobacco dependence
(Rigotti et al., 2012). Few hospitals treat tobacco dependence (Freund
et al., 2008), although effective interventions exist (Rigotti et al., 2012).
To be effective, it is critically important for hospitals to provide post-
discharge tobacco treatment that includes at least one month of sup-
portive counseling (Wier et al., 2011). Providing smoking cessation
medications for patients as an adjunct to counseling significantly im-
proves long term quit rates (Fiore et al., 2008). A number of studies
have examined methods for implementing these two elements of care
into hospital treatment and post-discharge care planning (Sherman
et al., 2016; Rigotti et al., 2016; Rigotti and Stoney, 2016; Richter et al.,
2016; Harrington et al., 2016; Fellows et al., 2016; Duffy et al., 2016;
Cummins et al., 2016).
Post-discharge smoking cessation treatment providing automated
telephone interactive voice response (IVR) counseling calls and free
medication increased biochemically verified quit rates by almost two-
fold (26% vs. 15%; RR 1.71, 95% CI, 1.14–2.56) in a single site study.
This study targeted all hospitalized patients (Rigotti et al., 2014).
However, in a multi-site study that incorporated the IVR-to quitline
transfer to test the scalability of this approach, the difference in ces-
sation rates was statistically significant at 3months but not at 6months
after hospital discharge (Rigotti et al., 2016). Few hospital-initiated
interventions have evaluated the relative and independent contribution
of individual features of multi-component interventions. Cummins et al.
(2016) used a factorial design to evaluate the effects of post-discharge
quitline and nicotine replacement on self-reported cessation at
6months. They observed a marginal effect (p=0.051) for post-dis-
charge pharmacotherapy on 6-month cessation and a non-significant
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effect for quitline counseling. Simon (Simon et al., 1997) conducted an
RCT of a multicomponent intervention including inpatient counseling,
self-help materials, NRT and 3months of telephone counseling post-
discharge vs. self-help materials only. Quit rates were higher in the
intervention group. Approximately 65% participants in the intervention
arm and nearly 20% in the self-help only arm reported using NRT,
however, NRT use was not significantly associated with quitting.
A better understanding of exactly what components post-discharge
treatment should consist of would assist with developing better inter-
ventions. The focus of this study is to determine the independent effects
of post-discharge counseling versus pharmacotherapy for cessation
among participants in a study of hospital-initiated smoking cessation.
Our analyses examine the effects of each on short and long-term ab-
stinence. We also adjust for the effects of short-term abstinence in order
to pinpoint the predictors of long-term abstinence.
2. Methods
2.1. Design and setting
This study is a secondary analysis of data from a clinical trial in
which hospitalized smokers were randomized to either warm handoff or
fax-referral to state tobacco quitline services for post-discharge treat-
ment (Richter et al., 2016; Richter et al., 2012). State quitlines are ef-
fective in helping smokers quit (Stead et al., 2013). The fax-referral arm
was the usual tobacco treatment care provided by the hospital tobacco
treatment staff. It consisted of a) assessing withdrawal; b) adjusting
inpatient nicotine replacement to enhance patient comfort; c) arranging
medication prescriptions on discharge; and d) developing a quit plan.
Staff fax-referred patients to the quitline on the day they were dis-
charged from the hospital. In the warm handoff arm, staff conducted
usual care steps a-c, then immediately linked patients with the quitline
via telephone for registration and completion of a quit plan with the
quitline provider. Alere Wellbeing provided quitline counseling, which
consisted of 5 proactive calls that addressed motivation, barriers, and
strategies for quitting and staying quit. Participants were enrolled in
two Kansas hospitals with dedicated tobacco treatment interventionists
on staff. Informed consent was obtained for all participants. The in-
stitutional review boards at both hospitals approved study protocols
and measures.
2.2. Participants and procedures
Hospitalized patients who were 18 years and older, smoked at least
1 cigarette within the past 30 days and were planning to stay quit post-
discharge were enrolled in the study (Richter et al., 2016; Richter et al.,
2012). Tobacco users were identified through the electronic health
record (EHR) and consented at bedside. The fax-referral arm was the
usual care provided by the hospital tobacco treatment staff. Counseling
was provided in one session and consisted of a) assessing withdrawal; b)
adjusting inpatient nicotine replacement to enhance patient comfort; c)
arranging medication prescriptions on discharge; and d) developing a
quit plan. In fax-referral, counselors faxed an enrollment form to the
quitline upon patient discharge, and the quitline contacted patients at
home to enroll patients in services.
In the warm handoff arm, staff conducted usual care steps a–c, then
called the state tobacco quitline and transferred the call to the patients'
mobile or bedside hospital phone for enrollment and an initial coun-
seling session. Alere Wellbeing (now Optum) provided quitline coun-
seling, which consisted of 5 proactive calls that addressed motivation,
barriers, and strategies for quitting and staying quit.
No medications were directly provided as part of the study and
prescribing hospital physicians were not part of the study team.
However, tobacco treatment in both study arms involved gauging pa-
tients' interest in smoking cessation medications. For interested pa-
tients, counselors worked with patients' hospital medical teams to
arrange medication scripts both in the hospital and on discharge.
Additional detail on study procedures are provided elsewhere (Richter
et al., 2016; Richter et al., 2012).
2.3. Measures
Total quitline counseling calls for each participant were provided by
Optum, the state quitline contractor. Self-reported smoking cessation
medication use (nicotine replacement therapy, varenicline, bupropion)
at one-month post-discharge was collected from participants via tele-
phone survey at 1-month. The baseline study survey included race and
ethnicity, highest level of education, Heaviness of Smoking Index (HSI)
(Heatherton et al., 1989), confidence in quitting/staying quit, previous
use of smoking cessation medications and other tobacco products.
Confidence in quitting was assessed using a single item: “How confident
are you that you will be able to quit/stay quit once you are discharged
from the hospital?” The item was scored on a 1 (Not at all confident) to 5
(Very confident) Likert scale. The AUDIT-C (Bush et al., 1998), a 3-item
measure, was used to assess problem drinking.
In addition, key study data were collected from the EHR. These
included: birth date; sex; health insurance; length of stay; whether
admission was through the emergency department (ED); and ICD-9
codes for primary and secondary discharge diagnoses. Primary diag-
noses were grouped into the major ICD-9 categories. We used a defined
list of ICD-9 codes to identify patients with tobacco-related diseases
(Lando et al., 2003). Primary or secondary psychiatric disorders were
indicated by ICD-9 codes 290-319, excluding 305.1 for tobacco use
disorder.
The dependent variables were self-reported 7-day point prevalent
abstinence at 1-month (7DPP) and biochemically verified abstinence 7-
day point prevalence at 6-months. Self-reported abstinence was as-
sessed during the 1-month telephone survey. Abstinence at 6-months
was verified via salivary cotinine. Participants with≤15 ng/ml salivary
cotinine were considered abstinent. Expired carbon monoxide (CO),
with a cut-off point of 10 ppm was used to verify abstinence in parti-
cipants still using NRT (SRNT, 2002).
2.4. Statistical analysis
Nine-hundred eighty-four of the original 1054 participants were
included in the present analysis (93.4% of all participants). Participants
(n=70) who were missing at both 1-month and 6-month follow-ups
were excluded. Participants included in this study (n=984) were
compared to participants lost to follow-up (n=70) on all baseline
characteristics. The participants who were lost to follow-up were sig-
nificantly less likely to have health insurance (84.1% vs. 94.3%,
p=0.002), less likely to be at-risk drinkers (14.5% vs. 31.7%,
p=0.004) and less likely to be assigned to the warm-hand off treat-
ment arm (37.7% vs. 50.9%, p=0.045) than the participants who were
not lost to follow-up. Descriptive statistics were calculated for the entire
sample as well as stratified by smoking status (abstinent versus still
smoking) and outcome (7DPP at 1-month and verified abstinence at 6-
months). Logistic regression was used to assess the relationship of the
predictor variables and outcome variables. Descriptive statistics for the
entire sample and stratified by smoking cessation outcome are pre-
sented in Table 1 along with bivariate odds ratios.
We used multivariable logistic regression models to determine the
adjusted odds of post-discharge treatment participation (use of coun-
seling and medications) for short and long-term abstinence. In ac-
cordance with guidelines for logistic regression, factors with p-va-
lues < 0.25 were selected for inclusion in the multivariable logistic
regression models (Hosmer and Lemeshow, 2000). Treatment arm, ni-
cotine dependence, gender, age, health insurance and high-risk
drinking (AUDIT-C) were included in the multivariable logistic re-
gression models regardless of p-value as these are known confounders
of cessation (Hyland et al., 2004). Intent-to-treat analysis was used,
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non-responders at 1-month (4.4%) and 6-months (11.3%) were treated
as smokers. Rates of missing data on the predictors in the sample were
low (0.2–5%). Our outcome measure at 1-month differed from our
outcome measure at 6months (self-report 7DPP versus biochemically
verified 7DPP abstinence). Multiple imputation with chained equations
(MICE) using 20 imputed datasets was used for both bivariate and
multivariable analyses (Royston and White, 2011). The analyses were




Baseline descriptive statistics for the overall sample and for smokers
abstinent at one and six months are presented in Table 1. Primary
reasons for hospitalization have been described in the main outcome
paper (Richter et al., 2016). Bivariate odds ratios (OR) assessing the
degree of association of each baseline predictor with each outcome are
also presented in Table 1. By 1-month, 456 subjects (46.3%) reported
7DPP abstinence. At 6-months, 267 (27.1%) subjects were verified
abstinent. The mean age of participants was 50 years, predominately
female (56%), White (71%) and were likely to have with-the majority
had some form of health insurance (94%). The median level of cigarette
consumption was 15 CPD and 72% of the sample reported daily
smoking (≥25/past 30 days). Seventy-two percent of the sample re-
ported smoking within 30min of waking.
With respect to post-hospitalization treatment engagement, 68.5%
of all participants completed at least one quitline call, 28% of all par-
ticipants reported using cessation pharmacotherapy, and 20% utilized
both quitline services and cessation pharmacotherapy. Of participants
who used pharmacotherapy, 85% used any form of nicotine replace-
ment therapy, 79% used the nicotine gum or patch, 5% bupropion, and
12% varenicline.
3.2. Bivariate predictors of 1-month and 6-month abstinence
Both post-discharge medication use and counseling participation
were associated with cessation outcomes. A greater total number of
quitline calls completed was associated with a significantly greater
likelihood of abstinence at 1-month (OR [95% CI]= 1.22 [1.13, 1.31],
p < 0.001) and at 6-months (OR [95% CI]= 1.30 [1.19, 1.41],
p < 0.001). Post-hospitalization pharmacotherapy use was also asso-
ciated with abstinence at 1-month (OR [95% CI]= 1.39 [1.05, 1.85],
p=0.02) and six months (OR [95% CI]= 1.43 [1.04, 1.95], p=0.03).
Lastly, abstinence at 1-month was strongly associated with abstinence
at 6-months (OR [95% CI]= 5.52 [4.02, 7.58], p < 0.001).
Among sociodemographic characteristics, education was the only
significant factor at 6months (Table 1). Having a tobacco-related dis-
ease diagnosis and not having a psychiatric diagnosis were significantly
associated with the likelihood abstinence at 1-month, but not at six
months. However, risk for heavy drinking, as measured using the
AUDIT-C, was associated with a lower likelihood of abstinence at 1-
month. With respect to nicotine dependence, HSI was significantly as-
sociated with cessation at 6-months.
Multiple participant characteristics were associated with the like-
lihood of abstinence at one and six months. Of the smoking related
variables, daily smoking was inversely associated with abstinence at 1-
month and 6months. Likewise, confidence in post-hospitalization
quitting was associated with abstinence at 1-month and 6months. A
longer length of stay (LOS) was also associated with abstinence at both
one and six months.
3.3. Multivariable model results
The results from the multivariable logistic regression models are
Table 1
Descriptive statistics and bivariate associations.
Total 7DPP at 1-month Verified quit at 6-months
Abstinent OR [95% CI] p-Value Abstinent OR [95% CI] p-Value
Age, mean (SD) 49.78 (12.91) 50.69 (13.44) 1.01 [1.00, 1.02] 0.041 51.21 (13.0) 1.01 [1.00, 1.02] 0.034
Female, n (%) 547 (55.6) 256 (56.1) 1.04 [0.81, 1.34] 0.747 155 (58.1) 1.15 [0.86, 1.52] 0.343
Married, n (%) 374 (38.1) 175 (38.4) 1.02 [0.79, 1.32] 0.858 100 (37.6) 0.97 [0.73, 1.30] 0.863
White race, n (%) 697 (70.8) 318 (69.7) 0.91 [0.69, 1.19] 0.482 185 (69.3) 0.90 [0.66, 1.23] 0.515
Black race, n (%) 261 (26.5) 123 (27.0) 1.04 [0.79, 1.39] 0.767 69 (25.8) 0.95 [0.69, 1.31] 0.768
Race other, n (%) 63 (6.4) 30 (6.6) 1.06 [0.63, 1.76] 0.834 24 (9.0) 1.72 [1.01, 2.91] 0.045
Hispanic, n (%) 60 (6.1) 29 (6.4) 0.91 [0.54, 1.54] 0.728 21 (7.9) 0.68 [0.39, 1.17] 0.163
Education > HS 509 (51.7) 238 (52.2) 1.04 [0.80, 1.33] 0.786 158 (59.2) 1.51 [1.14, 2.00] 0.004
Health insurance, n (%) 928 (94.3) 435 (95.4) 1.47 [0.84, 2.56] 0.174 254 (95.1) 1.25 [0.66, 2.36] 0.498
Lives w/ other smoker, n (%) 489 (49.7) 218 (47.8) 0.87 [0.67, 1.12] 0.271 142 (46.8) 0.85 [0.64, 1.13] 0.271
CPD, median (IQR) 15 (13.0) 12 (13.0) 0.99 [0.98, 1.01] 0.385 10 (14.0) 0.99 [0.97, 1.00] 0.088
Smokes≥ 25/30 days, n (%) 709 (72.1) 290 (63.6) 0.45 [0.34, 0.60] < 0.001 164 (61.4) 0.50 [0.37, 0.68] <0.001
E-cig use in past 30 days, n (%) 117 (11.9) 49 (10.8) 0.81 [0.55, 1.20] 0.292 36 (13.5) 1.22 [0.80, 1.85] 0.360
Other tobacco use, n (%) 76 (7.7) 34 (7.5) 1.07 [0.67, 1.72] 0.770 16 (6.0) 1.43 [0.81, 2.53] 0.217
TTFC < 30min, n (%) 705 (71.9) 315 (69.2) 0.78 [0.59, 1.03] 0.083 180 (67.7) 0.75 [0.55, 1.02] 0.067
HSI, mean (SD) 2.7 (1.65) 2.61 (1.69) 0.94 [0.87, 1.01] 0.119 2.51 (1.69) 0.91 [0.83, 0.99] 0.023
Confidence, mean (SD) 3.79 (1.12) 4 (1.05) 1.33 [1.18, 1.50] < 0.001 3.93 (1.08) 1.18 [1.03, 1.34] 0.014
At risk for heavy drinking, n (%) 312 (31.7) 128 (28.1) 0.73 [0.56, 0.96] 0.023 70 (26.2) 0.70 [0.51, 0.95] 0.024
At risk for depression, n (%) 525 (53.4) 229 (50.2) 0.79 [0.61, 1.01] 0.063 141 (52.8) 0.97 [0.73, 1.28] 0.821
Tobacco-related disease diagnosis, n (%) 404 (41.1) 209 (45.8) 1.44 [1.12, 1.86] 0.005 123 (46.1) 1.33 [1.00, 1.76] 0.052
Psychiatric diagnosis, n (%) 318 (32.3) 122 (26.8) 0.62 [0.47, 0.81] 0.001 85 (31.8) 0.97 [0.72, 1.31] 0.844
Admitted through ED, n (%) 585 (59.5) 285 (62.5) 1.27 [0.98, 1.64] 0.070 162 (60.7) 1.07 [0.80, 1.43] 0.634
LOS (days), median (IQR) 3.84 (4.39) 4.71 (5.45) 1.09 [1.06, 1.26] < 0.001 4.49 (4.46) 1.03 [1.00, 1.05] 0.036
Used meds post-hospitalization 264 (28.2) 144 (31.7) 1.39 [1.05, 1.85] 0.023 87 (33.5) 1.43 [1.04, 1.95] 0.026
Warm Handoff, n (%) 501 (50.9) 228 (50) 0.93 [0.73, 1.20] 0.594 134 (50.2) 0.96 [0.72, 1.27] 0.781
Quitline calls, median (IQR) 1 (3.0) 2 (4.0) 1.22 [1.13, 1.31] < 0.001 2 (3.0) 1.30 [1.19, 1.41] <0.001
Abstinent at 1 mo, n (%) – – – – – – – 201 (75.28) 5.52 [4.02, 7.58] <0.001
Note. 7DPP= seven-day point prevalence; OR=odds ratio; CPD= average cigarettes per day; TTFC= time to first cigarette; HSI=Heaviness of Smoking Index;
ED= emergency department; LOS= length of stay; SD= standard deviation; IQR= interquartile range.
Study location: Kansas, USA; study date: 2011–2014.
E.P. Liebmann, et al. Preventive Medicine Reports 15 (2019) 100937
3
presented in Table 2. Both using cessation pharmacotherapy post-hos-
pitalization as well as completing a greater number of quitline calls
were associated with abstinence at 1-month. Other predictors included
being a non-daily smoker, confidence, not having a psychiatric diag-
nosis, having a tobacco related disease diagnosis, admission through
the emergency department (ED), and a longer length of hospital stay.
After controlling for abstinence at 1-month, completing a greater
number of quitline calls was associated with 6-month verified ab-
stinence. Other predictors included non-daily smoking, having greater
than a high school education, and significantly associated with a
greater likelihood of abstinence. The model results using 7DPP ab-
stinence at 6-months were essentially identical, hence, we report the
model with the stronger outcome measure (biochemically verified ab-
stinence).
4. Discussion
When adjusting for known predictors of smoking cessation among
hospitalized smokers (Lando et al., 2003), both post-discharge phar-
macotherapy use and total number of quitline calls were associated
with short-term cessation. Only quitline utilization was associated with
long-term cessation. This is consistent with meta-analyses of hospital-
based tobacco cessation studies (Rigotti et al., 2012) and adds to this
literature by describing the independent effects of counseling and
medication to quitting within the same treatment sample.
Of particular note, quitline call engagement remained predictive of
cessation at 6-months even after adjusting for 1-month smoking ces-
sation. Quitline counseling facilitates smoking cessation by increasing
self-efficacy for cessation and developing skills related to coping with
cravings (Schuck et al., 2014). This suggests that quitline counseling
may have helped participants sustain their medication-assisted quit
attempts, and might also be particularly effective for those making
delayed quit attempts well after hospital discharge. One explanation for
this may be that the motivational processes underlying the cessation-
promoting effects of ‘teachable moments’ that occur during hospitali-
zation (McBride et al., 2003) may wane following discharge. Engaging
in counseling could build on that teachable moment to bolster the self-
efficacy and skills needed to quit at a later date. To improve utilization
of counseling calls, hospitals should ensure patients receive cessation
medications (which has been shown to increase call utilization) and
prepare patients for follow-up calls from the quitline (Burns et al., 2012;
Scheuermann et al., 2019).
Post-discharge use of cessation medication does not appear to have
this same effect. Its effect appeared limited to supporting 1-month ab-
stinence. After controlling for early abstinence it had no independent
effect on 6-month abstinence. The novel feature of the present study is
that we examined cessation at short and long term follow up, measured
participation in both counseling and medications, and accounted for the
effects of quitting at 1month. No other studies, including the factorial
design trial conducted by Cummins et al., controlled for the effects of
early abstinence. This is perhaps why the study was able to distinguish
between the effects of counseling and medications at 6months.
The present study also contributes to the existing literature on
barriers and facilitators related to smoking cessation among hospita-
lized smokers. Only one in four used medications post discharge. The
relatively low rate of pharmacotherapy use is notable given the high
rates of health insurance in this sample. Although most private and
public insurers are required to cover cessation medications, compliance
may not be consistent and some proportion of patients may not have
used medications due to inability to get their prescriptions filled.
In addition, Similar to Bentz et al., we found that only two-thirds of
participants, all of whom were referred to quitline, engaged in coun-
seling (Bentz et al., 2006). The effects of confidence and smoking re-
lated-illness observed in the present analysis are consistent with other
studies (Lando et al., 2003; MacKenzie et al., 2004). In addition, the
effects of psychiatric diagnosis and longer length of hospital stay ob-
served in the present analysis coincide with findings from a study of
post-discharge smoking relapse among patients hospitalized for acute
coronary syndrome (Perez et al., 2008).
In contrast to the present study, Cummins' (Cummins et al., 2016)
factorial experiment achieved a marginal effect for post-discharge
pharmacotherapy on 6-month cessation and a non-significant effect for
quitline counseling. Findings may differ between studies due to dif-
ferent utilization patterns: Cummins' trial had a lower rate of post-
discharge quitline counseling in the quitline arm (47%) versus the
present study (68%) but achieved a higher rate of pharmacotherapy
utilization (67%) than the current study (29%).
This study has several limitations. The relative contribution of
pharmacotherapy and quitline services to cessation could not be defi-
nitively ascertained due to selection bias—participants were not ran-
domly assigned to receive these interventions. The most motivated to
quit, or able to do so, may have been more likely to use pharma-
cotherapy or engage in quitline services. We tried to control for this by
adjusting for known predictors of cessation. In addition, the study re-
cruited patients who intended to stay quit post-hospitalization. The
findings may not generalize to other hospital settings or to patients who
are not motivated to quit. In addition, we were not able to measure
whether participants actually filled the prescriptions for medication
they were discharged with, which could have been a meaningful pre-
dictor of cessation.
We were not able to test the phenomenon of reverse causation be-
cause of insufficient data to examine the temporal associations between
individual counseling calls/medication use and smoking status long-
itudinally. It is possible that smokers who were having more success
with quitting were more likely than those who relapsed to persist with
medication use and counseling. Also, odds ratios generated from the









Warm handoff vs. fax referral 0.85 [0.64, 1.13] 0.86 [0.63, 1.20]
Age 1.00 [0.99, 1.01] 1.00 [0.99, 1.02]
Female 1.04 [0.78, 1.39] 0.97 [0.70, 1.34]
Has insurance 1.32 [0.72, 2.41] 0.87 [0.43, 1.76]
Other race 1.52 [0.80, 2.89]
Hispanic 0.69 [0.36, 1.33]
Edu. > high school 1.58⁎⁎ [1.15, 2.18]
Smokes≥ 25/30 days 0.58⁎⁎ [0.42, 0.81] 0.63⁎ [0.44, 0.90]
HSI 0.96 [0.88, 1.05] 0.95 [0.86, 1.05]
Confident 1.22⁎⁎ [1.07, 1.38] 1.02 [0.88, 1.18]
Used other tobacco products 1.42 [0.75, 2.67]
Alcohol use disorder 0.80 [0.59, 1.09] 0.82 [0.57, 1.18]
Possible depression 0.87 [0.65, 1.15]
Psychiatric comorbidity 0.72⁎ [0.54, 0.98]
Tobacco-related disease diagnosis 1.46⁎ [1.08, 1.96] 1.14 [0.81, 1.60]
ED admission 1.51⁎⁎ [1.14, 2.01]
LOS (days) 1.09⁎⁎⁎ [1.06,
1.13]
1.00 [0.97, 1.03]
Used meds. post-discharge 1.45⁎ [1.06, 1.99] 1.27 [0.89, 1.82]
Total quitline calls 1.25⁎⁎⁎ [1.14,
1.36]
1.23⁎⁎⁎ [1.12, 1.35]
Abstinent at 1 mo. 4.67⁎⁎⁎ [3.33, 6.54]
Note. OR=odds ratio; HSI=Heaviness of Smoking Index; ED= emergency
department; LOS= length of stay; 7DPP= seven-day point prevalence;
Meds= smoking cessation pharmacotherapy (NRT, varenicline, bupropion).
Study location: Kansas, USA; study date: 2011–2014.
⁎ p < 0.05.
⁎⁎ p < 0.01.
⁎⁎⁎ p < 0.001.
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5. Conclusions
Post-discharge counseling may have a latent effect on long-term
cessation. The benefits of post-discharge pharmacotherapy and quitline
services is contingent upon patients accessing and using these re-
sources. Thus, enhancing smokers' uptake of pharmacotherapy and
quitline services—and enhancing medication adherence and utilization
of coaching calls—are important and synergistic strategies for im-
proving the efficacy of hospital-initiated intervention.
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